Author:
Marchetti O, ,Lamoth F,Mikulska M,Viscoli C,Verweij P,Bretagne S
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference65 articles.
1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
2. ECIL. Recommendations for the use of biological markers for the diagnosis of invasive fungal infections in leukemic patients and hematopoietic stem cell transplant recipients. 2010 ( http://www.ichs.org ; http://www.eortc.be ; http://www.ebmt.org ; http://www.leukemia-net.org/content/home/ ).
3. Mennink-Kersten MA, Donnelly JP, Verweij PE . Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349–357.
4. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2008: (8): CD007394.
5. Pfeiffer CD, Fine JP, Safdar N . Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417–1427.
Cited by
220 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献